KEIO RESEARCHERS INFORMATION SYSTEM

Career 【 Display / hide 】

Career 【 Display / hide 】

• 1993.05

  -

  Present

  Department of Pediatrics, Keio School of Medicine

Academic Background 【 Display / hide 】

Academic Background 【 Display / hide 】

• 1993.03

  Keio University, 医学部

  University, Graduated

Academic Degrees 【 Display / hide 】

Academic Degrees 【 Display / hide 】

• 医学博士, 慶應義塾大学医学部, 2002.03

Licenses and Qualifications 【 Display / hide 】

Licenses and Qualifications 【 Display / hide 】

• 医師免許, 1993.05

• 日本小児科学会 小児科専門医, 1997.04

• 日本感染症学会 感染症専門医, 2006.10

• 日本感染症学会 感染症指導医, 2012.03

• インフェクションコントロールドクター（ICD)認定, 2001.01

Research Areas 【 Display / hide 】

Research Areas 【 Display / hide 】

• Life Science / Embryonic medicine and pediatrics

• Life Science / Infectious disease medicine

Research Keywords 【 Display / hide 】

Research Keywords 【 Display / hide 】

• influenza

• immunization after liver transplantation

Research Themes 【 Display / hide 】

Research Themes 【 Display / hide 】

• 細菌性髄膜炎, 

  2011.06

  -

  Present

• 肝移植とワクチン, 

  2000.04

  -

  Present

• インフルエンザ, 

  1997.08

  -

  Present

Papers 【 Display / hide 】

Papers 【 Display / hide 】

• Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season

  Shinjo(h) Masayoshi

  VACCINE 36 （ 37 ） 5510 - 5518 2018.09

  Research paper (scientific journal),  ISSN  0264-410X

  • Access to Document (DOI)

• Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design

  Kimiya, Takahisa, Shinjoh, Masayoshi, Anzo, Makoto, Takahashi, Hiroki, Sekiguchi, Shinichiro, Sugaya, Norio, Takahashi, Takao

  EUROPEAN JOURNAL OF PEDIATRICS 177 （ 7 ） 1009 - 1017 2018.07

  Research paper (scientific journal),  ISSN  0340-6199

  • Access to Document (DOI)

• Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design

  Kimiya Takahisa, Shinjoh Masayoshi, Anzo Makoto, Takahashi Hiroki, Sekiguchi Shinichiro, Sugaya Norio, Takahashi Takao

  European Journal of Pediatrics    1 - 9 2018.04

  ISSN  0340-6199

  　View Summary

  <p>Both traditional case-control studies (TCCSs) and test-negative case-control studies (TNCCSs) are commonly used to assess influenza vaccine effectiveness (VE). To compensate for the fact that observational studies are susceptible to bias, we combined both methods to assess VE in one geographical area during the 2015/2016 season, when influenza A (H1N1)pdm was dominant. Our TNCCS covered 331 children aged 6 months to 15 years who visited our hospital with fever, including 182 with influenza, and our TCCS covered 812 pediatric outpatients aged 6 months to 15 years, including 214 with influenza. Influenza infection and vaccination history were reviewed, and VE was calculated as (1 − odds ratio) × 100. In the TNCCS, VE against influenza A was 68% (95% CI 47–81) overall, and 70% (48–83) for those given two doses; against influenza B, VE was 37% (− 12–64) overall and 49% (2–74) for two doses. In the TCCS, VE against influenza A was 44% (15–63) overall and 44% (13–64) for two doses, and VE against influenza B was 24% (− 19–52) overall and 41% (3–64) for two doses. Conclusion: Both studies confirmed significant VE against influenza A, significant two-dose VE against influenza B, and better two-dose VE than one-dose VE.(Table presented.)</p>

  • Access to Document (DOI)

• Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016

  Shinjo(h) Masayoshi

  VACCINE 36 （ 8 ） 1063 - 1071 2018.02

  Research paper (scientific journal),  ISSN  0264-410X

  • Access to Document (DOI)

• Purulent lymphadenitis caused by Staphylococcus argenteus, representing the first Japanese case of Staphylococcus argenteus (multilocus sequence type 2250) infection in a 12-year-old boy

  Ohnishi Takuma, Shinjoh Masayoshi, Ohara Hirotoshi, Kawai Toshinao, Kamimaki Isamu, Mizushima Ryo, Kamada Keisuke, Itakura Yasutomo, Iguchi Shigekazu, Uzawa Yutaka, Yoshida Atsushi, Kikuchi Ken

  Journal of Infection and Chemotherapy  2018.01

  ISSN  1341-321X

  　View Summary

  <p>Staphylococcus argenteus is a novel species separated from a strain of coagulase-positive, non-pigmented S. aureus. Although S. argenteus has been reported to occur globally, multilocus sequence type (ST) 2250 is mainly found in Northeastern Thailand. Because conventional biochemical testing misidentifies this pathogen as S. aureus, multilocus sequence typing (MLST) or nucA sequencing is recommended to distinguish between S. argenteus and S. auereus. The patient was a previously healthy 12-year-old boy who was admitted because of right inguinal lymphadenitis and cellulitis. Although intravenous cefazolin was administered, his lymphadenitis worsened and formed an abscess on day 6 of hospitalization. Incision and drainage were performed on day 7 of hospitalization. Cefazolin was changed to oral cefaclor, and the patient was successfully treated over a period of 5 weeks. No recurrence was observed throughout 12-months of follow-up. He had a history of right axillary lymph node abscess 2 months before this admission, which was successfully treated with incision, drainage, and antibiotic therapy. He has lived in Japan since birth and never traveled abroad. He had no opportunity to interact with foreigners. His immune function, especially neutrophil function, was tested and we did not find any dysfunction. First, methicillin-sensitive S. aureus was misidentified from the abscess culture. Subsequently, the causative agent was re-identified as S. argenteus ST2250 based on MLST. To our knowledge, this is the first case of S. argenteus ST2250 infection in Japan. This pathogen should be taken into consideration in the diagnosis if the patient has atypical non-pigmented S. aureus.</p>

  • Access to Document (DOI)

display all >>

Papers, etc., Registered in KOARA 【 Display / hide 】

Papers, etc., Registered in KOARA 【 Display / hide 】

• Safe and effective immunizations with live-attenuated vaccines for patients after living donor liver transplantation

  SHINJOH, MASAYOSHI

  科学研究費補助金研究成果報告書 2008

Presentations 【 Display / hide 】

Presentations 【 Display / hide 】

• Effective post-exposure prophylaxis for influenza in pediatric wards

  Shinjo(h) Masayoshi

  TRANSMISSION OF RESPIRATORY VIRUSES:from basic science to evidence based options for control (Hong Kong) , 

  2017.06

  , 

  Poster presentation

• Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation

  Shinjo(h) Masayoshi

  11th Congress of Asian Society for Pediatric Research (Osaka, Japan) , 

  2015.04

  , 

  Oral presentation (general)

• Estimated effectiveness of influenza vaccine using influenza rapid diagnostic tests　- test-negative case-control study among Japanese children

  Shinjo(h) Masayoshi

  3rd isirv-Antiviral Group Conference, 

  2014.06

  , 

  Poster presentation

• Post-exposure Prophylaxis For Influenza in Pediatric Wards: Oseltamivir or Zanamivir After Rapid Antigen Detection

  Shinjo(h) Masayoshi

  Second isirv AVG conference - Severe Influenza: Burden, Pathogenesis and Management, 

  2012.10

  , 

  Poster presentation

• Efficient and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation.

  SHINJO(H) MASAYOSHI

  FOURTH WORLD CONGRESS ON VACCINES AND IMMUNIZATION (Tsukuba, Japan) , 

  2004.10

  , 

  Oral presentation (general)

display all >>

Research Projects of Competitive Funds, etc. 【 Display / hide 】

Research Projects of Competitive Funds, etc. 【 Display / hide 】

• 小児患者における、ESBL産生腸内細菌の検出頻度に関する研究

  2011.04

  -

  2012.03

  森永奉仕会研究奨励金, Principal investigator

• 生体肝移植後における、安全かつ効果的な生ワクチン接種

  2006.04

  -

  2009.03

  科研費, Principal investigator

• ノイラミニダーゼ阻害薬を用いたインフルエンザの発症予防

  2004.04

  -

  2006.03

  科研費, Grant-in-Aid for Scientific Research, Research grant, Principal investigator

• 小児インフルエンザ脳症・脳炎発症のメカニズムの解明

  2001.04

  -

  2003.03

  科研費, Principal investigator

Awards 【 Display / hide 】

Awards 【 Display / hide 】

• 最優秀賞（演題）

  Keio Pediatric Influenza Research group, 2014.10, 第63回日本感染症学会東日本地方会学術集会, 小児インフルエンザワクチンの効果 -迅速診断を用いた　test-negative case-control study-

Courses Taught 【 Display / hide 】

Courses Taught 【 Display / hide 】

• LECTURE SERIES, PEDIATRICS

  2024

• INFECTIOUS DISEASES

  2024

• LECTURE SERIES, PEDIATRICS

  2023

• INFECTIOUS DISEASES

  2023

• LECTURE SERIES, PEDIATRICS

  2022

display all >>

Courses Previously Taught 【 Display / hide 】

Courses Previously Taught 【 Display / hide 】

• 小児科

  慶應義塾大学医学部

  2018.04

  -

  2019.03

• 小児感染症

  Keio University

  2014.04

  -

  2015.03

  , 

  Full academic year, Lecture

• 感染症学

  慶應義塾大学医学部

  2018.04

  -

  2019.03

• ワクチン

  Keio University

  2014.04

  -

  2015.03

  , 

  Full academic year, Lecture

• 小児科学

  慶應義塾大学薬学部

  2018.04

  -

  2019.03

display all >>

Educational Activities and Special Notes 【 Display / hide 】

Educational Activities and Special Notes 【 Display / hide 】

• 第8回慶應義塾大学病院臨床研修指導医育成講習会受講

  2003.07

  -

  Present

  , Device of Educational Contents

  　View Details

  補講　2014年6月28日

• OSCE評価認定講習会修了

  2012.09

  -

  Present

  , Device of Educational Contents

• 慶應義塾大学医療系三学部合同教育 中期教育ワークショップ　2013

  2013.09

  -

  Present

  , Device of Educational Contents

• 慶應義塾大学医療系三学部合同教育 中期教育ワークショップ　2014

  2014.09

  -

  Present

  , Device of Educational Contents

Memberships in Academic Societies 【 Display / hide 】

Memberships in Academic Societies 【 Display / hide 】

• 公益社団法人　日本小児科学会

  　

• 一般社団法人　日本感染症学会

  　

• 日本小児感染症学会

  　

• 一般社団法人　日本環境感染学会

  　

• 公益社団法人　日本小児保健協会

  　

Committee Experiences 【 Display / hide 】

Committee Experiences 【 Display / hide 】

• 2004.10

  -

  Present

  評議員, 一般社団法人　日本感染症学会

• 2002

  -

  Present

  評議員, 日本小児感染症学会

• 2013.03

  -

  2015

  評議員, 一般社団法人　日本環境感染学会